Clinical Trials
6 trialsNCT05768139 2026-05-22
PIKALO-1
Eli Lilly and Company
Phase 1/2 Recruiting
NCT03280563 2025-11-10
MORPHEUS HR+BC
Hoffmann-La Roche
Phase 1/2 Completed
NCT04079517 2025-02-06
Karisma-1
Karolinska Institutet
Phase 1/2 Completed
NCT02285179 2022-10-12
Poseidon
The Netherlands Cancer Institute
Phase 1/2 Completed
NCT00290745 2020-12-04
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
University of California, San Francisco
Phase 1/2 Completed
NCT01194908 2015-01-26
Re-expression of ER in Triple Negative Breast Cancers
Emory University
Phase 1/2 Terminated